Amar Gajjar

58.4k total citations · 6 hit papers
429 papers, 23.5k citations indexed

About

Amar Gajjar is a scholar working on Genetics, Neurology and Molecular Biology. According to data from OpenAlex, Amar Gajjar has authored 429 papers receiving a total of 23.5k indexed citations (citations by other indexed papers that have themselves been cited), including 279 papers in Genetics, 138 papers in Neurology and 122 papers in Molecular Biology. Recurrent topics in Amar Gajjar's work include Glioma Diagnosis and Treatment (278 papers), Neuroblastoma Research and Treatments (118 papers) and Childhood Cancer Survivors' Quality of Life (62 papers). Amar Gajjar is often cited by papers focused on Glioma Diagnosis and Treatment (278 papers), Neuroblastoma Research and Treatments (118 papers) and Childhood Cancer Survivors' Quality of Life (62 papers). Amar Gajjar collaborates with scholars based in United States, Canada and Australia. Amar Gajjar's co-authors include Larry E. Kun, Thomas E. Merchant, Richard J. Gilbertson, Raymond K. Mulhern, Alberto Broniscer, Wilburn E. Reddick, David W. Ellison, Shawna L. Palmer, Christine Fuller and Mehmet Koçak and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Genetics and Journal of Clinical Oncology.

In The Last Decade

Amar Gajjar

413 papers receiving 23.1k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A Perivascular Niche for Brain Tumor Stem Cells

2007 1.7k citations Christopher Calabrese, Amar Gajjar et al. profile →
Molecular subgroups of medulloblastoma: the current consensus

2011 1.2k citations Paul A. Northcott, Amar Gajjar et al. profile →
Late neurocognitive sequelae in survivors of brain tumours in childhood

2004 648 citations Thomas E. Merchant, Amar Gajjar et al. profile →
Phase III Study of Craniospinal Radiation Therapy Followed by Adjuvant Chemotherapy for Newly Diagnosed Average-Risk Medulloblastoma

2006 637 citations Roger J. Packer, Amar Gajjar et al. Journal of Clinical Oncology profile →
Radial glia cells are candidate stem cells of ependymoma

2005 579 citations Christopher Calabrese, Amar Gajjar et al. profile →
Medulloblastoma

2019 384 citations Paul A. Northcott, Giles Robinson et al. profile →

Peers

Countries citing papers authored by Amar Gajjar

Since Specialization

Citations

This map shows the geographic impact of Amar Gajjar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amar Gajjar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amar Gajjar more than expected).

Fields of papers citing papers by Amar Gajjar

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amar Gajjar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amar Gajjar. The network helps show where Amar Gajjar may publish in the future.

Co-authorship network of co-authors of Amar Gajjar

This figure shows the co-authorship network connecting the top 25 collaborators of Amar Gajjar. A scholar is included among the top collaborators of Amar Gajjar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amar Gajjar. Amar Gajjar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Phase 3 randomized trial of high-dose methotrexate for young children with high-risk embryonal brain tumors: A report from the Children’s Oncology Group 2025 ·Neuro-Oncology ·Claire Mazewski, Sarah Leary, Guolian Kang, Bryan Li, Stewart J. Kellie, Laura L. Hayes, Dennis Shaw, Ben Ho, Alyssa Reddy, Jeffrey M. Gossett, Peter C. Burger, Alexander R. Judkins, (unknown), J. Russell Geyer, Amar Gajjar, Ian F. Pollack, Maryam Fouladi, Annie Huang	3
2	Intensive Interdisciplinary Rehabilitation in the Pediatric Hematology/Oncology Setting: Feasibility and Perceived Benefit of the Acute Neurological Injury Service 2024 ·Cancers ·Darcy Raches, Amar Gajjar, Giles Robinson, Jason M. Ashford, (unknown), (unknown), (unknown), Allison Harris, Hannah Taylor, (unknown), Heather M. Conklin	0
3	Comprehensive analysis of MYB/MYBL1-altered pediatric-type diffuse low-grade glioma 2024 ·UNC Libraries ·Paul Klimo, (unknown), Matthew D. Wood, (unknown), Alan Davidson, Xiaoyu Li, Giles Robinson, Daniel C. Moreira, (unknown), Jason Chiang, (unknown), Ibrahim Qaddoumi, Thomas W. Bouldin, Meenakshi Devidas, Amar Gajjar, Ryuma Tanaka, Godwin Job	1
4	Comparison of DNA methylation based classification models for precision diagnostics of central nervous system tumors 2024 ·npj Precision Oncology ·Quynh T. Tran, (unknown), Tong Lin, Ruth Tatevossian, Sariah J. Allen, Michael R. Clay, Larissa V. Furtado, Jinan Chen, Dale J. Hedges, (unknown), Giles Robinson, Paul A. Northcott, Amar Gajjar, Elizabeth M. Azzato, Sheila Shurtleff, David W. Ellison, Stanley Pounds, Brent A. Orr	4
5	Social cognition and adjustment in adult survivors of pediatric central nervous system tumors 2023 ·Cancer ·(unknown), Victoria W. Willard, Amar Gajjar, Thomas E. Merchant, Deo Kumar Srivastava, Gregory T. Armstrong, Melissa M. Hudson, Kevin R. Krull, Tara M. Brinkman	4
6	Social participation of school‐aged survivors of pediatric brain tumors: A daily diary report 2023 ·Pediatric Blood & Cancer ·(unknown), (unknown), Niki Jurbergs, Heather M. Conklin, Amar Gajjar, Victoria W. Willard	4
7	Clinical features, neurologic recovery, and risk factors of postoperative posterior fossa syndrome and delayed recovery: a prospective study 2021 ·Neuro-Oncology ·Raja B. Khan, Zoltán Patay, Paul Klimo, Jie Huang, Rahul Kumar, Frederick A. Boop, Darcy Raches, Heather M. Conklin, Richa Sharma, (unknown), Zsila Sadighi, Arzu Onar‐Thomas, Amar Gajjar, Giles Robinson	47
8	Phase II trial of response-based radiation therapy for patients with localized germinoma: a Children’s Oncology Group study 2021 ·Neuro-Oncology ·Ute Bartels, Arzu Onar‐Thomas, Sunita K. Patel, Dennis Shaw, Jason Fangusaro, Girish Dhall, Mark M. Souweidane, Aashim Bhatia, Leanne Embry, Christine L. Trask, Erin S. Murphy, Shannon M. MacDonald, Shengjie Wu, James M. Boyett, Sarah Leary, Maryam Fouladi, Amar Gajjar, Soumen Khatua	32
9	Phase I/II trial of vorinostat and radiation and maintenance vorinostat in children with diffuse intrinsic pontine glioma: A Children’s Oncology Group report 2021 ·Neuro-Oncology ·Jack Su, Lindsay Kilburn, David B. Mansur, Mark Krailo, Allen Buxton, (unknown), Amar Gajjar, Peter C. Adamson, Brenda J. Weigel, Elizabeth Fox, Susan M. Blaney, Maryam Fouladi	39
10	Creation of a successful multidisciplinary course in pediatric neuro‐oncology with a systematic approach to curriculum development 2020 ·Cancer ·Daniel C. Moreira, Amar Gajjar, Zoltán Patay, Frederick A. Boop, Jason Chiang, Thomas E. Merchant, Teresa Santiago, (unknown), (unknown), (unknown), (unknown), Miguela A. Caniza, Carlos Rodríguez‐Galindo, Ibrahim Qaddoumi	8
11	Exposure–Toxicity Association of Cyclophosphamide and Its Metabolites in Infants and Young Children with Primary Brain Tumors: Implications for Dosing 2019 ·Clinical Cancer Research ·Olivia Campagne, (unknown), (unknown), Tong Lin, Jie Huang, Arzu Onar‐Thomas, Giles Robinson, Amar Gajjar, Clinton F. Stewart	19
12	Establishing a Preclinical Multidisciplinary Board for Brain Tumors 2018 ·Clinical Cancer Research ·Birgit Nimmervoll, Nidal Boulos, (unknown), Jason Dapper, Michael DeCuypere, Anang A. Shelat, (unknown), (unknown), Amar Gajjar, Yogesh T. Patel, Burgess B. Freeman, Arzu Onar‐Thomas, Clinton F. Stewart, Martine F. Roussel, (unknown), Thomas E. Merchant, Christopher Calabrese, Karen Wright, Richard J. Gilbertson	9
13	Common variants in ACYP2 influence susceptibility to cisplatin-induced hearing loss 2015 ·Nature Genetics ·Heng Xu, Giles Robinson, Jie Huang, (unknown), Hui Zhang, Johnnie K. Bass, Alberto Broniscer, Murali Chintagumpala, Ute Bartels, S. Gururangan, Tim Hassall, Michael J. Fisher, Richard J. Cohn, Tetsuji Yamashita, Tal Teitz, Jian Zuo, Arzu Onar‐Thomas, Amar Gajjar, Clinton F. Stewart, Jun Yang	92
14	Phase I Trial, Pharmacokinetics, and Pharmacodynamics of Vandetanib and Dasatinib in Children with Newly Diagnosed Diffuse Intrinsic Pontine Glioma 2013 ·Clinical Cancer Research ·Alberto Broniscer, Sharyn D. Baker, Cynthia Wetmore, Atmaram S. Pai Panandiker, Jie Huang, Andrew M. Davidoff, Arzu Onar‐Thomas, John C. Panetta, Thomas K. Chin, Thomas E. Merchant, Justin N. Baker, Sue C. Kaste, Amar Gajjar, Clinton F. Stewart	74
15	Phase I Study of Vismodegib in Children with Recurrent or Refractory Medulloblastoma: A Pediatric Brain Tumor Consortium Study 2013 ·Clinical Cancer Research ·Amar Gajjar, Clinton F. Stewart, David W. Ellison, Sue C. Kaste, Larry E. Kun, Roger J. Packer, Stewart Goldman, Murali Chintagumpala, Dana Wallace, Naoko Takebe, James M. Boyett, Richard J. Gilbertson, Tom Curran	164
16	Genome-Wide Analyses Identify Recurrent Amplifications of Receptor Tyrosine Kinases and Cell-Cycle Regulatory Genes in Diffuse Intrinsic Pontine Glioma 2011 ·Journal of Clinical Oncology ·Barbara S. Paugh, Alberto Broniscer, Chunxu Qu, Claudia P. Miller, Junyuan Zhang, Ruth Tatevossian, James M. Olson, J. Russell Geyer, Susan Chi, Nasjla Saba da Silva, Arzu Onar‐Thomas, Justin N. Baker, Amar Gajjar, David W. Ellison, Suzanne J. Baker	219
17	Clinical Pharmacokinetics of Amifostine and WR1065 in Pediatric Patients with Medulloblastoma 2010 ·Clinical Cancer Research ·(unknown), John C. Panetta, Maryam Fouladi, Amar Gajjar, Feng Bai, M. Fatih Okcu, Clinton F. Stewart	11
18	Tyrosine Kinase Inhibitor Enhances the Bioavailability of Oral Irinotecan in Pediatric Patients With Refractory Solid Tumors 2009 ·Journal of Clinical Oncology ·Wayne L. Furman, Fariba Navid, Najat C. Daw, M. Beth McCarville, Lisa M. McGregor, Sheri L. Spunt, Carlos Rodríguez‐Galindo, John C. Panetta, Kristine R. Crews, Jianrong Wu, Amar Gajjar, Peter J. Houghton, Victor M. Santana, Clinton F. Stewart	42
19	Population Pharmacokinetic Analysis of Topotecan in Pediatric Cancer Patients 2007 ·Clinical Cancer Research ·Paula Schaiquevich, John C. Panetta, Lisa Iacono, Burgess B. Freeman, Victor M. Santana, Amar Gajjar, Clinton F. Stewart	16
20	Phase III Study of Craniospinal Radiation Therapy Followed by Adjuvant Chemotherapy for Newly Diagnosed Average-Risk Medulloblastoma breakdown → 2006 ·Journal of Clinical Oncology ·Roger J. Packer, Amar Gajjar, Gilbert Vézina, Lucy B. Rorke‐Adams, Peter C. Burger, Patricia L. Robertson, Lisa A. Bayer, Deborah A. Lafond, Bernadine R. Donahue, (unknown), Karin M. Muraszko, James Langston, Richard Sposto	637

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact